Cardiovascular technologist

Multi Board-Certified Physician Sam Setareh Opens MDVIP-Affiliated Primary Care Practice in Los Angeles

Retrieved on: 
Wednesday, February 14, 2024
Pharmacy, Cedars-Sinai Medical Center, American Heart Association, LOS, Suite, Molina Healthcare, Physician, Mount Sinai West, AHA, Cardiovascular disease, Cardiovascular technologist, MDVIP, ESC, Heart failure, Textbook, Health, University, Innovation, Medicare, Internal medicine, American College, Executive, Patient, Journal, European Society of Cardiology, Public key certificate, ACC, Athlete, Partnership

LOS ANGELES and BOCA RATON, Fla., Feb. 14, 2024 /PRNewswire/ -- MDVIP, the market leader in personalized healthcare with a network of over 1,100 physicians nationwide, today announced the opening of a new MDVIP-affiliated internal medicine practice in Los Angeles. Sam Setareh, M.D., M.S., F.A.C.C., is currently accepting patients who want a more direct relationship with their primary care physician. Dr. Setareh brings an impressive and diversified background to MDVIP, including four board certifications in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology and Echocardiology, and he is an attending physician at Cedars-Sinai Medical Center in Los Angeles.  Dr. Setareh serves as a member of multiple committees on the American College of Cardiology and the American Heart Association and as a founding member of the editorial board of The Journal of Scientific Innovation in Medicine.

Key Points: 
  • , is currently accepting patients who want a more direct relationship with their primary care physician.
  • Dr. Setareh brings an impressive and diversified background to MDVIP, including four board certifications in Internal Medicine, Cardiovascular Disease, Nuclear Cardiology and Echocardiology, and he is an attending physician at Cedars-Sinai Medical Center in Los Angeles.
  • "As an MDVIP-affiliated primary care physician, my mission is to help empower patients to take better control of their health through preventive medicine and highly individualized care," said Dr. Setareh, who has subspecialties in preventive cardiology, sports cardiology and advanced cardiovascular imaging.
  • He has treated and taken care of patients from all walks of life, including the most vulnerable to heads-of-state, dignitaries, athletes, celebrities and physician colleagues.

UltraSight and EchoNous Partner to Enable More Accessible Cardiac Ultrasound for Patients

Retrieved on: 
Friday, June 23, 2023
American Society of Echocardiography, Heart, Plague, Partnership, Stanford University, Cardiovascular technologist, Intelligence, Android, Doctor of Philosophy, IOS, Acquisition, Patient, ASE, Diagnosis, FDA, Society, Medical device, Medical imaging, MD, Cosmos

NATIONAL HARBOR, Md., June 23, 2023 /PRNewswire/ -- Today, UltraSight, a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced a partnership with point-of-care ultrasound innovator EchoNous, to enable more healthcare professionals to perform cardiac ultrasound and help increase patient access to cardiac care. The new collaboration was announced at ASE 2023, the premier event for bringing together echo professionals.

Key Points: 
  • NATIONAL HARBOR, Md., June 23, 2023 /PRNewswire/ -- Today, UltraSight , a digital health pioneer transforming cardiac imaging through the power of artificial intelligence, announced a partnership with point-of-care ultrasound innovator EchoNous, to enable more healthcare professionals to perform cardiac ultrasound and help increase patient access to cardiac care.
  • "Empowering a greater number of healthcare professionals in more care settings to conduct cardiac ultrasound brings us one step closer to realizing our vision of making cardiac care more equitable for patients around the world," said UltraSight CEO Davidi Vortman.
  • UltraSight's real-time AI guidance software will be integrated with EchoNous' KOSMOS handheld ultrasound device with the goal of enabling chronic cardiac patient monitoring to be done closer to patients.
  • By separating the acquisition and interpretation of ultrasound images, UltraSight technology has the potential to improve access to optimized cardiac care and more cost-effective heart monitoring opportunities.

Artificial Intelligence Improves Coronary Artery Disease Detection, New Study Finds

Retrieved on: 
Thursday, December 16, 2021
Oregon Health & Science University, NHSX, Society, FDA, American Society of Echocardiography, Prognosis, Degenerative disease, Physician, Radiation, Intelligence, Health, College of Engineering and Physical Sciences (University of Guelph), NHS, CAD, Science, Mark (given name), Artificial intelligence, Clinical professor, Time, Review, AI, National Institute, Cardiology, Risk, CEO, Research, Association, Patient, European Association for the Study of the Liver, Disease, Coronary artery disease, Cardiovascular disease, Workflow, Cardiovascular technologist, Eye, University, GLS, Classification, Deep learning, Partnership, Department of Computer Science, University of Oxford, Mayo Clinic, Medical imaging, Medical device, Echocardiography

OXFORD, England, Dec. 16, 2021 /PRNewswire/ --A new study published today , Automated Echocardiographic Detection of Severe Coronary Artery Disease Using Artificial Intelligence , found that Ultromics' EchoGo platform, powered by Artificial Intelligence (AI), significantly improved the accuracy and confidence in coronary artery disease (CAD) detection from a stress echocardiogram.

Key Points: 
  • OXFORD, England, Dec. 16, 2021 /PRNewswire/ --A new study published today , Automated Echocardiographic Detection of Severe Coronary Artery Disease Using Artificial Intelligence , found that Ultromics' EchoGo platform, powered by Artificial Intelligence (AI), significantly improved the accuracy and confidence in coronary artery disease (CAD) detection from a stress echocardiogram.
  • Ultromics' has developed an AI algorithm that automatically analyzes stress echocardiograms and tells the clinician whether that patient is at risk of coronary artery disease.
  • During the first portion of the study, Ultromics AI was trained and tested to identify patients with severe coronary artery disease.
  • The fact that we can now apply artificial intelligence to echocardiography to perform at this level is truly revolutionary for patient care".

Artificial Intelligence Improves Coronary Artery Disease Detection, New Study Finds

Retrieved on: 
Wednesday, December 15, 2021
Oregon Health & Science University, NHSX, Society, FDA, American Society of Echocardiography, Prognosis, Degenerative disease, Physician, Radiation, Intelligence, Health, College of Engineering and Physical Sciences (University of Guelph), NHS, CAD, Science, Mark (given name), Artificial intelligence, Clinical professor, Time, Review, AI, National Institute, Cardiology, Risk, CEO, Research, Association, Patient, European Association for the Study of the Liver, Disease, Coronary artery disease, Cardiovascular disease, Workflow, Cardiovascular technologist, Eye, University, GLS, Classification, Deep learning, Partnership, Department of Computer Science, University of Oxford, Mayo Clinic, Medical imaging, Medical device, Echocardiography

OXFORD, England, Dec. 15, 2021 /PRNewswire/ --A new study published today , Automated Echocardiographic Detection of Severe Coronary Artery Disease Using Artificial Intelligence , found that Ultromics' EchoGo platform, powered by Artificial Intelligence (AI), significantly improved the accuracy and confidence in coronary artery disease (CAD) detection from a stress echocardiogram.

Key Points: 
  • OXFORD, England, Dec. 15, 2021 /PRNewswire/ --A new study published today , Automated Echocardiographic Detection of Severe Coronary Artery Disease Using Artificial Intelligence , found that Ultromics' EchoGo platform, powered by Artificial Intelligence (AI), significantly improved the accuracy and confidence in coronary artery disease (CAD) detection from a stress echocardiogram.
  • Ultromics' has developed an AI algorithm that automatically analyzes stress echocardiograms and tells the clinician whether that patient is at risk of coronary artery disease.
  • During the first portion of the study, Ultromics AI was trained and tested to identify patients with severe coronary artery disease.
  • The fact that we can now apply artificial intelligence to echocardiography to perform at this level is truly revolutionary for patient care".

Caption Health Announces JAMA Cardiology Publication Showing Effectiveness of AI-Guided Ultrasound Software

Retrieved on: 
Thursday, February 18, 2021
Medical ultrasonography, Medicine, Cardiology, Medical specialties, Classical mechanics, Medical physics, Medical ultrasound, Physical therapy, Echocardiography, Cardiovascular technologist, Medical imaging, Sonographer

The Caption AI platform, which includes Caption Guidance and Caption Interpretation, is the first and only AI-guided medical imaging acquisition software to obtain FDA clearance, enabling a broad range of healthcare workers to perform cardiac ultrasound examinations at the point of care.

Key Points: 
  • The Caption AI platform, which includes Caption Guidance and Caption Interpretation, is the first and only AI-guided medical imaging acquisition software to obtain FDA clearance, enabling a broad range of healthcare workers to perform cardiac ultrasound examinations at the point of care.
  • Each patient in the study underwent paired ultrasounds: one from a nurse, and one from an experienced registered diagnostic cardiac sonographer.
  • In addition to further refinements of its cardiac ultrasound guidance, Caption Health recently received a $4.95 million grant from the Bill & Melinda Gates Foundation to develop AI-guided lung ultrasound software.
  • The complete study, " Utility of a Deep Learning Algorithm to Guide Novices to Acquire Limited Diagnostic Echocardiograms ", is now available to read online in JAMA Cardiology.

B-Secur Receives FDA Regulatory Clearance For Its HeartKey® EKG/ECG Technology

Retrieved on: 
Thursday, February 4, 2021
Cardiology, Biotechnology, Technology, FDA, Other Health, Health, Radiology, Other Technology, Medical devices, Software, Hospitals, Branches of biology, Medicine, Cardiac electrophysiology, Clinical medicine, Electrodiagnosis, Cardiology, Electrocardiography, Electrophysiology, Food and Drug Administration, Cardiovascular technologist

B-Secur , a leader in EKG/ECG technology, today announced that it has received U.S. Food and Drug Administration (FDA) 510(K) clearance of its HeartKey software library1.

Key Points: 
  • B-Secur , a leader in EKG/ECG technology, today announced that it has received U.S. Food and Drug Administration (FDA) 510(K) clearance of its HeartKey software library1.
  • This clearance should significantly aid our partners and customers increase the speed to market for their technology.
  • FDA clearance has been granted for the following EKG/ECG feature algorithms: Signal Conditioning, Heart Rate and Arrhythmia Analysis.
  • FDA clearance of the HeartKey software library ensures B-Secur customers and partners can have confidence in its world-leading algorithm performance and accuracy.

Medable Partners with AliveCor For In-Home ECG Testing

Retrieved on: 
Wednesday, April 29, 2020
Medical devices, Health, Clinical trials, Research, Cardiology, Science, Medicine, Health, Branches of biology, Cardiac electrophysiology, Alivecor, Cardiology, Pharmaceutical industry, Clinical trial, Cardiovascular technologist, Kardia, Electrocardiography, Medable, AliveCor

As an integrated capability within the Medable platform, KardiaMobile 6L removes a key barrier to enabling in-home clinical trials.

Key Points: 
  • As an integrated capability within the Medable platform, KardiaMobile 6L removes a key barrier to enabling in-home clinical trials.
  • Standard ECG machines require a trained technician or nurse, which make them an obstacle for in-home testing.
  • At AliveCor, we are committed to making medical-grade ECG technology accessible no matter where a patient is, said AliveCor CEO Priya Abani.
  • Together, Medable and AliveCor aim to accelerate development of therapies by expanding research and improving convenience of trials.

BulletinHealthcare Partners with the American Society of Echocardiography to Launch News Briefing

Retrieved on: 
Thursday, October 18, 2018
Medical ultrasonography, Medicine, Cardiology, Health, Medical imaging, Cardiac imaging, American Society of Echocardiography, Echocardiography, Cardiovascular technologist, Medical ultrasound

RESTON, Va., Oct. 18, 2018 /PRNewswire/ -- BulletinHealthcare, a leading provider of news briefings for top medical associations, today announced that it has launched its latest briefing to members of the American Society of Echocardiography (ASE).

Key Points: 
  • RESTON, Va., Oct. 18, 2018 /PRNewswire/ -- BulletinHealthcare, a leading provider of news briefings for top medical associations, today announced that it has launched its latest briefing to members of the American Society of Echocardiography (ASE).
  • The content of the briefing follows BulletinHealthcare's signature curation and distillation of the day's most important news stories by BulletinHealthcare's team of healthcare experts.
  • The briefing focuses on the news most relevant to the nation's practicing echocardiographers.
  • As the largest global organization for cardiovascular ultrasound imaging, the American Society of Echocardiography (ASE) is the leader and advocate, setting practice standards and guidelines.